{"id":9004111222146390,"date":"2026-10-30T11:24:25","date_gmt":"2026-10-30T11:24:25","guid":{"rendered":"https:\/\/www.hgf.com\/?p=9004111222146390"},"modified":"2026-10-30T14:23:19","modified_gmt":"2026-10-30T14:23:19","slug":"seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu","status":"publish","type":"post","link":"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/","title":{"rendered":"Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU."},"content":{"rendered":"<p>We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU.<\/p>\n<p><strong><em>Speaker: Dr Andrew Wells (Partner and Head of the HGF Chemistry &amp; Pharmaceutical Group)<\/em><\/strong><\/p>\n<p>For any medicine marketed in Europe, a key commercial consideration is the timing of generic or biosimilar market entry. Protection from competition is derived from two principal sources: intellectual property rights (patents and Supplementary Protection Certificates), and regulatory exclusivities. The new EU Pharma Package introduces changes to the regulatory exclusivities that are available.<\/p>\n<p>In this seminar, Dr Andrew Wells will explain the proposed reforms and discuss what they mean for both innovator and generic pharmaceutical companies.<\/p>\n<p>We look forward to welcoming you to the seminar.<\/p>\n<div class=\"btn-wrap btn-wrap--mb\"><a href=\"\" class=\"btn on-grey\" target=\"_blank\"><span>REGISTER HERE<\/span><\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. Speaker: Dr Andrew Wells (Partner and &hellip;<\/p>\n","protected":false},"author":502,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[504,505,497],"tags":[],"class_list":["post-9004111222146390","post","type-post","status-publish","format-standard","hentry","category-events","category-hgf-event","category-knowledge-hub"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.8 (Yoast SEO v28.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. - HGF<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU.\" \/>\n<meta property=\"og:description\" content=\"We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. Speaker: Dr Andrew\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/\" \/>\n<meta property=\"og:site_name\" content=\"HGF\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-30T11:24:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-30T14:23:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hgf.com\/wp-content\/uploads\/2023\/04\/hgf-logo-1200x675-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Georgia Melia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hgf_ip\" \/>\n<meta name=\"twitter:site\" content=\"@hgf_ip\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Georgia Melia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/knowledge-hub\\\/events\\\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/knowledge-hub\\\/events\\\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\\\/\"},\"author\":{\"name\":\"Georgia Melia\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/person\\\/7df0a22a79ff7cc91642cd3ce4882036\"},\"headline\":\"Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU.\",\"datePublished\":\"2026-10-30T11:24:25+00:00\",\"dateModified\":\"2026-10-30T14:23:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/knowledge-hub\\\/events\\\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\\\/\"},\"wordCount\":165,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Events\",\"HGF Event\",\"Knowledge Hub\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/knowledge-hub\\\/events\\\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\\\/\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/knowledge-hub\\\/events\\\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\\\/\",\"name\":\"Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. - HGF\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#website\"},\"datePublished\":\"2026-10-30T11:24:25+00:00\",\"dateModified\":\"2026-10-30T14:23:19+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hgf.com\\\/fr\\\/knowledge-hub\\\/events\\\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/\",\"name\":\"HGF\",\"description\":\"Intellectual Property Rights specialists\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#organization\",\"name\":\"HGF\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/hgf-logo-696x696-1.png\",\"contentUrl\":\"https:\\\/\\\/www.hgf.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/hgf-logo-696x696-1.png\",\"width\":696,\"height\":696,\"caption\":\"HGF\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hgf_ip\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hgf-limited-intellectual-property-specialists\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hgf.com\\\/fr\\\/#\\\/schema\\\/person\\\/7df0a22a79ff7cc91642cd3ce4882036\",\"name\":\"Georgia Melia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc759620959e751b0f1ac49d89cb60b8f62218f980cb9e4919ee6eb01c4fed6f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc759620959e751b0f1ac49d89cb60b8f62218f980cb9e4919ee6eb01c4fed6f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc759620959e751b0f1ac49d89cb60b8f62218f980cb9e4919ee6eb01c4fed6f?s=96&d=mm&r=g\",\"caption\":\"Georgia Melia\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. - HGF","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/","og_locale":"fr_FR","og_type":"article","og_title":"Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU.","og_description":"We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. Speaker: Dr Andrew","og_url":"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/","og_site_name":"HGF","article_published_time":"2026-10-30T11:24:25+00:00","article_modified_time":"2026-10-30T14:23:19+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hgf.com\/wp-content\/uploads\/2023\/04\/hgf-logo-1200x675-1.png","type":"image\/png"}],"author":"Georgia Melia","twitter_card":"summary_large_image","twitter_creator":"@hgf_ip","twitter_site":"@hgf_ip","twitter_misc":{"\u00c9crit par":"Georgia Melia","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/#article","isPartOf":{"@id":"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/"},"author":{"name":"Georgia Melia","@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/person\/7df0a22a79ff7cc91642cd3ce4882036"},"headline":"Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU.","datePublished":"2026-10-30T11:24:25+00:00","dateModified":"2026-10-30T14:23:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/"},"wordCount":165,"publisher":{"@id":"https:\/\/www.hgf.com\/fr\/#organization"},"articleSection":["Events","HGF Event","Knowledge Hub"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/","url":"https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/","name":"Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. - HGF","isPartOf":{"@id":"https:\/\/www.hgf.com\/fr\/#website"},"datePublished":"2026-10-30T11:24:25+00:00","dateModified":"2026-10-30T14:23:19+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hgf.com\/fr\/knowledge-hub\/events\/seminar-on-the-new-eu-pharma-package-and-its-implications-for-regulatory-exclusivities-in-the-eu\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.hgf.com\/fr\/#website","url":"https:\/\/www.hgf.com\/fr\/","name":"HGF","description":"Intellectual Property Rights specialists","publisher":{"@id":"https:\/\/www.hgf.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hgf.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.hgf.com\/fr\/#organization","name":"HGF","url":"https:\/\/www.hgf.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.hgf.com\/wp-content\/uploads\/2023\/04\/hgf-logo-696x696-1.png","contentUrl":"https:\/\/www.hgf.com\/wp-content\/uploads\/2023\/04\/hgf-logo-696x696-1.png","width":696,"height":696,"caption":"HGF"},"image":{"@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hgf_ip","https:\/\/www.linkedin.com\/company\/hgf-limited-intellectual-property-specialists\/"]},{"@type":"Person","@id":"https:\/\/www.hgf.com\/fr\/#\/schema\/person\/7df0a22a79ff7cc91642cd3ce4882036","name":"Georgia Melia","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/bc759620959e751b0f1ac49d89cb60b8f62218f980cb9e4919ee6eb01c4fed6f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bc759620959e751b0f1ac49d89cb60b8f62218f980cb9e4919ee6eb01c4fed6f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bc759620959e751b0f1ac49d89cb60b8f62218f980cb9e4919ee6eb01c4fed6f?s=96&d=mm&r=g","caption":"Georgia Melia"}}]}},"_links":{"self":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts\/9004111222146390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/users\/502"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/comments?post=9004111222146390"}],"version-history":[{"count":5,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts\/9004111222146390\/revisions"}],"predecessor-version":[{"id":9004111222146399,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/posts\/9004111222146390\/revisions\/9004111222146399"}],"wp:attachment":[{"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/media?parent=9004111222146390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/categories?post=9004111222146390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hgf.com\/fr\/wp-json\/wp\/v2\/tags?post=9004111222146390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}